Page last updated: 2024-09-05

methyl 4-azidophenylacetimidate and MS (Multiple Sclerosis)

methyl 4-azidophenylacetimidate has been researched along with MS (Multiple Sclerosis) in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Elkama, A; Karahalil, B; Orhan, G1

Other Studies

1 other study(ies) available for methyl 4-azidophenylacetimidate and MS (Multiple Sclerosis)

ArticleYear
Association of vitamin D receptor polymorphisms with vitamin D and calcium levels in Turkish multiple sclerosis patients.
    Neurodegenerative disease management, 2022, Volume: 12, Issue:6

    Topics: Calcium; Genetic Predisposition to Disease; Humans; Multiple Sclerosis; Receptors, Calcitriol; Vitamin D; Vitamins

2022